Furthermore, the investigators report, the reduction of risk was on a par with traditional antidiabetic drugs, including rosiglitazone, metformin, acarbose, and ramipril.

• 研究人员还说，羟基氯喹对糖尿病风险的降低与传统抗糖尿病药相当，后者包括罗格列酮、二甲双胍、阿卡波糖和雷米普利。